Compare Cassava Sciences Inc (FLNA) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Occidental Petroleum Corporation — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Occidental Petroleum Corporation trades at $54.04 (market cap $53.48B). The key difference: Occidental Petroleum Corporation is far larger — about 1006.4× Cassava Sciences Inc's market cap, and Occidental Petroleum Corporation pays a 1.93% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | OXY | |
|---|---|---|
Market Cap | $53.14M | $53.48B |
Sector | Health | Energy |
52-Week High | $4.64 | $66.24 |
52-Week Low | $1.09 | $38.92 |
Enterprise Value | -$33.43M | $74.57B |
Dividend Yield | — | 1.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Occidental Petroleum (OXY) trades at $54.02, down 1.01% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 5. Recent news highlights improved capital efficiency and debt reduction, while analyst consensus shows 50% buy ratings with a $66.14 price target. Revenue has declined from $36.6B in 2022 to $21.6B in 2025, though net margins remain healthy at 10.77%.
OXY presents a mixed outlook with strong operational performance and analyst optimism offset by declining revenue trends. The stock offers potential upside to consensus targets but faces risks from oil price volatility and execution challenges under new leadership. Key catalysts include Q2 earnings and continued progress on debt reduction initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
